Search
Scandinavian Medical Solutions (SMS) was listed on Nasdaq First North Growth Market in Denmark on November 3, 2021. Since then, we've achieved strong financial growth. In November 2023, we announced plans to establish a U.S. subsidiary, which launched in early 2024, expanding our presence in the Americas. As part of this, our founder, Jens Krohn, became CEO of the U.S. subsidiary, and Jens Hvid Paulsen took over as CEO of SMS.
With ambitious plans ahead, we remain committed to delivering value to our shareholders through strategic growth and operational excellence.
To keep our investors and stakeholders informed, we provide a real-time overview of the SMSMED share, including the latest stock price and historical performance.
We remain committed to transparency and value creation. Follow our progress as we expand our global presence and stay updated with live market data.
Login on Scandinavian Medical Solutions' shareholder portal, where you as a shareholder can access to numerous shareholder information including your shareholdings, chose what information you wish to receive and sign up for the Scandinavian Medical Solutions annual general meeting or submit a power of attorney.
Gasvaerksvej 48. 1st Floor Right DK-9000 Aalborg
VAT: 39 90 17 49
HC Andersen Capital - Bredgade 23B 2. sal, 1260 København K
VAT: 41 47 47 93
